|
Arterial thrombosis
Citations 261-270 of 336 total displayed.
|
Past content
(since Oct 2000):
|
- Clinical Investigations and Reports
Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors
- Dwayne S.G. Conway, Lesly A. Pearce, Bernard S.P. Chin, Robert G. Hart, and Gregory Y.H. Lip
Circulation 2002;106:1962-1967; published online before print as doi:10.1161/01.CIR.0000033220.97592.9A
[Abstract]
[Full text]
- Basic Science Reports
Different Mechanisms of Increased Luminal Stenosis After Arterial Injury in Mice Deficient for Urokinase- or Tissue-Type Plasminogen Activator
- Katrin Schäfer, Stavros Konstantinides, Carsten Riedel, Therese Thinnes, Katja Müller, Claudia Dellas, Gerd Hasenfuss, and David J. Loskutoff
Circulation 2002;106:1847-1852; published online before print as doi:10.1161/01.CIR.0000031162.80988.2B
[Abstract]
[Full text]
- Editorials
Evidence-Based Risk Stratification to Target Therapies in Acute Coronary Syndromes
- Christopher P. Cannon
Circulation 2002;106:1588-1591, doi:10.1161/01.CIR.0000030416.80014.F4
[Full text]
- Clinical Investigations and Reports
Plasma von Willebrand Factor and Soluble
P-Selectin as Indices of Endothelial Damage and
Platelet Activation in 1321 Patients With Nonvalvular
Atrial Fibrillation. Relationship to Stroke Risk
Factors
- Dwayne S.G. Conway, Lesly A. Pearce, Bernard S.P. Chin, Robert G. Hart, and Gregory Y.H. Lip
Circulation published September 23, 2002, doi:10.1161/01.CIR.0000033220.97592.9A
[Abstract]
- Clinical Investigations and Reports
Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes: The COMPARE Trial
- Wayne B. Batchelor, Thaddeus R. Tolleson, Yao Huang, Rhonda L. Larsen, R. Michael Mantell, Patricia Dillard, Marie Davidian, Daowen Zhang, Warren J. Cantor, Michael H. Sketch, Jr, E. Magnus Ohman, James P. Zidar, Daniel Gretler, Peter M. DiBattiste, James E. Tcheng, Robert M. Califf, and Robert A. Harrington
Circulation 2002;106:1470-1476; published online before print as doi:10.1161/01.CIR.0000029744.01096.1F
[Abstract]
[Full text]
- Clinical Investigations and Reports
Sirolimus-Eluting Stents for the Treatment of Obstructive Superficial Femoral Artery Disease: Six-Month Results
- Stephan H. Duda, Benjamin Pusich, Goetz Richter, Peter Landwehr, Vincent L. Oliva, Alexander Tielbeek, Benjamin Wiesinger, Jan Bart Hak, Hans Tielemans, Gerhard Ziemer, Ecatarina Cristea, Alexandra Lansky, and Jean P. Bérégi
Circulation 2002;106:1505-1509; published online before print as doi:10.1161/01.CIR.0000029746.10018.36
[Abstract]
[Full text]
- Articles
Different Mechanisms of Increased Luminal Stenosis After Arterial Injury in Mice Deficient for Urokinase- or Tissue-Type Plasminogen Activator
- Katrin Schäfer, Stavros Konstantinides, Carsten Riedel, Therese Thinnes, Katja Müller, Claudia Dellas, Gerd Hasenfuss, and David J. Loskutoff
Circulation published September 16, 2002, doi:10.1161/01.CIR.0000031162.80988.2B
[Abstract]
- Articles
Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes. The COMPARE Trial
- Wayne B. Batchelor, Thaddeus R. Tolleson, Yao Huang, Rhonda L. Larsen, R. Michael Mantell, Patricia Dillard, Marie Davidian, Daowen Zhang, Warren J. Cantor, Michael H. Sketch, Jr, E. Magnus Ohman, James P. Zidar, Daniel Gretler, Peter M. DiBattiste, James E. Tcheng, Robert M. Califf, and Robert A. Harrington
Circulation published September 3, 2002, doi:10.1161/01.CIR.0000029744.01096.1F
[Abstract]
- Articles
Sirolimus-Eluting Stents for the Treatment of Obstructive Superficial Femoral Artery Disease. Six-Month Results
- Stephan H. Duda, Benjamin Pusich, Goetz Richter, Peter Landwehr, Vincent L. Oliva, Alexander Tielbeek, Benjamin Wiesinger, Jan Bart Hak, Hans Tielemans, Gerhard Ziemer, Ecatarina Cristea, Alexandra Lansky, and Jean P. Bérégi
Circulation published August 26, 2002, doi:10.1161/01.CIR.0000029746.10018.36
[Abstract]
- Editorials
Platelet-Derived CD40L: The Switch-Hitting Player of Cardiovascular Disease
- Patrick André, Lisa Nannizzi-Alaimo, Srinivasa K. Prasad, and David R. Phillips
Circulation 2002;106:896-899, doi:10.1161/01.CIR.0000028962.04520.01
[Full text]
|
|
